SEC Form 4 · accession 0000920465-15-000046
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Saiid Zarrabian
Director
Period of report
May 14, 2015
Accepted (ET)
May 15, 2015 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | P | 307 | $19.50 | A | 688 | I | For Children |
| Common Stock | holding | — | — | — | 109,231 | D |
Table II — derivative securities
No Table II lines on this filing.